![]() |
市场调查报告书
商品编码
1618264
下垂脚治疗设备:市场洞察·竞争环境·市场预测 (~2030年)Foot Drop Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
在 2024 年至 2030 年的预测期内,足下垂治疗设备市场规模预计将以 8.15% 的复合年增长率成长。
由于包括多发性硬化症在内的慢性神经系统疾病盛行率上升、下肢疼痛病例数量增加以及人口老化等因素,足下垂治疗设备市场呈现出显着的市场成长。
足下垂治疗设备:市场动态
根据世界卫生组织资料(2023 年),据报导全球有超过 180 万人患有多发性硬化症。此疾病影响多种功能,包括认知、情绪、运动、感觉和视觉能力。当免疫系统错误地攻击大脑和脊髓时,就会发生多发性硬化症。多发性硬化症的增加是足下垂治疗设备需求的主要驱动力,因为多发性硬化症通常会导致运动障碍,包括足部下垂。多发性硬化症会损害运动功能和独立性,需要先进的解决方案,例如功能性电刺激器来恢復行走。
根据世界卫生组织2021年发布的数据,2015年至2050年间,60岁及以上老年人跌倒的比例将从12%翻倍至22%,到2050年,全球将有21亿人遭受跌倒之苦。此外,到 2030 年,六分之一的人将年龄在 60 岁或以上。世界人口老化增加了中风、週边神经病变和退化性疾病等与年龄相关的疾病的盛行率,这些都是导致足下垂的主要原因。因此,对治疗设备的需求不断增长,以提高老年人的运动能力和改善生活品质。
依产品类型划分,电刺激设备细分市场在 2023 年将占据显着的收入占有率。这是因为它的非侵入性、恢復功能性运动的能力以及重新训练肌肉的有效性。
这些设备采用先进的功能性电刺激技术来激活背屈肌,改善步态并降低跌倒风险。便携性、客製化选项和可穿戴设计使其适合日常使用。此外,人们越来越认识到其在中风和多发性硬化症等神经系统疾病的康復和治疗中的应用,也支持了该产品的广泛使用。
本报告提供全球下垂脚治疗设备的市场调查,彙整市场概要,市场影响因素及市场机会分析,法律制度,市场规模的转变·预测,各种区分·地区/各主要国家的详细分析,竞争情形,主要企业简介等资讯。
Foot Drop Treatment Devices Market by Product Type (Electrical Stimulator and Braces/Splints), Application (Neuropathy, Muscle Disorders, Brain & Spinal Disorders, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the rising prevalence of chronic neurological disorders and the growing cases of lower limb pain worldwide
The foot drop treatment devices market is projected to grow at a CAGR of 8.15% during the forecast period from 2024 to 2030. The foot drop treatment devices market is observing substantial market growth primarily owing to the rising prevalence of chronic neurological disorders including multiple sclerosis, growing cases of lower limb pain, and the rising geriatric population that are expected to escalate the overall growth of the foot drop treatment devices market during the forecast period from 2024 to 2030.
Foot Drop Treatment Devices Market Dynamics:
As per data from the World Health Organization (WHO) (2023), it was reported that over 1.8 million people worldwide are affected by multiple sclerosis. It impacts various functions including cognitive, emotional, motor, sensory, and visual abilities. It occurs when the immune system mistakenly attacks the brain and the spinal cord. The prevalence of multiple sclerosis significantly drives the demand for foot drop treatment devices, as multiple sclerosis often leads to motor impairments, including foot drop. The condition disrupts mobility and independence, requiring advanced solutions like functional electrical stimulators to restore gait.
As per data provided by the WHO 2021, between 2015 and 2050, people falling between 60 years and above will be doubled from 12 to 22%, and will eventually reach 2.1 billion by 2050, globally. Moreover, by 2030, 1 in 6 people will age 60 years or above. The aging global population increases the prevalence of age-related conditions like stroke, peripheral neuropathy, and degenerative disorders, which are major causes of foot drop. This drives the demand for treatment devices to enhance mobility and improve the quality of life in elderly individuals.
Therefore, all the factors stated above collectively will drive the overall foot drop treatment devices market growth.
However, the side effects associated with prolonged usage, fitting-related issues, and others may prove to be challenging factors for the foot drop treatment devices market growth during the forecast period.
Foot Drop Treatment Devices Market Segment Analysis:
Foot Drop Treatment Devices Market by Product Type (Electrical Stimulator and Braces/Splints), Application (Neuropathy, Muscle Disorders, Brain & Spinal Disorders, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the foot drop treatment devices, the electrical stimulator category is expected to have a significant revenue share in the year 2023. This is due to their non-invasive nature, ability to restore functional movement, and effectiveness in re-educating muscles.
These devices use advanced functional electrical stimulation technology to activate dorsiflexor muscles, improving gait and reducing the risk of falls. Their portability, customization options, and compatibility with wearable designs make them convenient for daily use. Additionally, the increasing awareness about their therapeutic benefits and their application in rehabilitation for neurological conditions like stroke and multiple sclerosis is further expected to drive their adoption.
Therefore, the widespread uses and key features of electrical stimulators that enhance their performance are solidifying the impact on the growth of the overall foot drop treatment devices market, during the forecast period from 2024 to 2030.
North America is expected to dominate the overall foot drop treatment devices market:
Among all the regions, North America is expected to dominate the foot drop treatment devices market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high instances of guillain-barre syndrome, increasing cases of lower limb pain combined with significant advancements in product development & regulatory approvals, the presence of market key players, and the availability of well-established advanced healthcare infrastructure; acting as key factors contributing to the growth of the foot drop treatment devices market in the North America region during the forecast period from 2024 to 2030.
According to data from the Centers of Disease Control and Prevention (2023), it was stated that guillain-barre syndrome is a rare disorder in which the body's immune system mistakenly attacks the peripheral nerves. This damage to the nerves leads to muscle weakness and, in some cases, paralysis. In the United States, an estimated 3,000 to 6,000 people develop guillain-barre syndrome each year. Thus the rising cases of guillain-barre syndrome is increasing demand for foot drop treatment devices as guillain-barre syndrome often causes nerve damage leading to muscle weakness and foot drop.
Further, the Centre for Disease Control and Prevention (2021), stated that the percentage of adults experiencing lower limb pain rose with age, starting at 21.0% for individuals aged 18-29, increasing to 28.8% for those aged 30-44, 43.4% for adults aged 45-64, and reaching 50.3% for those aged 65 and over. The increasing prevalence of lower limb pain with age is driving the demand for foot drop treatment devices. As more individuals experience knee issues or age-related pain, the likelihood of developing foot drop increases, creating a larger patient base for assistive devices to improve mobility and quality of life.
Additionally, the prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional foot drop treatment devices market growth. The presence of key players with their strong distribution networks ensures widespread availability and accessibility of these devices across the region, thus increasing their revenue shares in the market, along with supportive reimbursement programs providing immense growth opportunities for the same.
Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American foot drop treatment devices market.
Foot Drop Treatment Devices Market key players:
Some of the key market players operating in the foot drop treatment devices market include Ottobock, Bioness Inc, AxioBionics, Saebo, Inc., OrthoPediatrics Corp., Turbomed Orthotics, Ossur, Thrive Orthopedics, Allard USA Inc., NextStep Robotics, Arthrex, Inc., Evolution Devices, Narang Medical Limited, AliMed, Cionic, and others.
Recent Developmental Activities in the Foot Drop Treatment Devices Market:
Key Takeaways from the Foot Drop Treatment Devices Market Report Study
Target Audience who can be benefited from this Foot Drop Treatment Devices Market Report Study
Frequently Asked Questions for the Foot Drop Treatment Devices Market: